SlideShare a Scribd company logo
1 of 1
Acknowledgements
Overview of X-Chem
Internship Description
Skills and Knowledge
Biochemistry Research Associate Intern in X-Chem Pharmaceuticals
Jingyi (Zooey) Wang
X-Chem, Inc 100 Beaver Street, Suite 101, Waltham, MA 02453-8425, USA
Science of X-Chem
1.Overview
X-Chem is a privately held biotechnology company established
in 2009, whose chemical strategy can be applied broadly to
most targets in any therapeutic area. A strong team of leading
experts has been built with proven track records in innovative
drug discovery and biotechnology partnering.
2.Development History
X-Chem was founded in 2009 by industry veterans Richard
Wagner, Brant Binder and Gordon Binder. A strategic
partnership of X-Chem and Pharmaceutical Product
Development , LLC(PPD) was formed in 2010. In 2014, PPD
exercised its option to acquire all remaining interests in X-
Chem, while the company’s management, scientific staff and
biotechnology business model was retained.
3.Partners
The company has established collaborations with eight of the
leading pharmaceutical companies, top tier biotechnology
companies, academic centers as well as non-profit institutions.
Novel lead compounds has been generated against dozens of
high-value therapeutic targets.
When and How I got this position?
I applied the Internship position through Massachusetts Life
Science Internship Challenge (MSLC) in January of 2016. In
the middle of March, with Dr. Neil Simister’s recommendation,
I got the position at X-Chem and started working full-time at
May 12. I have been working under the Biochemistry and Cell
Biology group and under the supervising by Julie Liu, Senior
Research Scientist.
1. Skills and knowledge I had that were useful in
the internship.
• The Background Knowledge learned from Molecular
Biotechnology, Advanced cell Biology courses.
• Experiment skills gained from Project Lab and
Biochemistry Lab courses.
2. Gained Skills and Knowledge from Internship
• Knowledge
a. Drug discovery and business
b. Troubleshoot experiment
c. Lab Technics
• Multiple Biochemistry assays
a. ELISA Assay
b. AlphaLISA Assay
c. Malachite Green Assay
d. Solubility assay
• Instruments
a. Mosquito: Multichannel dispenser which can dispense
lower to 20nl.
b. Multidrop Dispensers: Dispense reagents into plate
and fill plate in seconds.
c. Multichannel Pipettes
d. Microplate Washers: Microplate strip washers
provide secure washing performance for routine and
research ELISA applications.
• Data Analysis
My Contribution to X-Chem
What I did during the internship?
• Prepare stock for compounds
• Perform biochemical assays
• Analyze data
• Present results in the group meeting
• Keep track of the compound inventory
• Keep a record
• X-Fit
I would like to thank Dr. Neil Simister, X-Chem and MSLC
internship challenge for providing me the opportunity to
work and learn throughout the internship.
I would like to thank my supervisor Julie Liu and the
biochemistry and cell biology group member for all the
help, patience and mentorship during the internship.
Phase1: Library design and synthesis - Both chemistry and
encoding steps occurring during the split.
Phase2: Affinity Selection of library - Using affinity-tagged
protein target yields a selected population of library members.
Phase3: Amplification, Clustering and Sequencing (Illumina) -
Giving a very deep sampling of the demographics of the
enriched population.
Phase4: Translation of Sequence - Providing chemical and
statistical information and the sequence is evaluated to
discover putative chemotypes.
Phase5: Off-DNA compounds synthesis - Representative
compounds exploring putative chemotypes with the desired
enrichment profiles are synthesized off-DNA.
Phase6: Biochemical assay - Target modulation is assessed
by biochemical assay.
Figure A Figure B
Figure A: Inhibition curve for one compound (XCMPD004206). The y-axis
shows the percentage of inhibition of target activity and the x-axis shows the
concentration of compound in log scale. The 50% inhibition concentration for
this compound is 0.002789uM.
Figure B: Solubility curve for one compound (XCMPD004928). The y-axis
shows the counts from Photodetector and the x-axis shows the concentration
of compound in log scale. The solubility for this compound is 77.95uM
Program 3: Malachite Green Assay
1.Program Purpose: Identifying inhibitors of the target for
the treatment of autoimmune diseases, cancer.
2.Assay Principle:
Program 4: Solubility Assay
1.Program Purpose: Setting up the solubility database for
compounds of X-Chem. The solubility data can help the
group to evaluate the compounds.
2.Assay Principle:
Detects particles in liquid samples by measuring forward
scattered light.
Program 1: ELISA Assay
1.Program Purpose: Identifying inhibitors of the target
which is related to potent anaphylatoxin, cell Lysis,
proinflammatory, prothrombotic, chemotaxis.
2.Assay principle:
Program 2: AlphaLISA Assay
1.Program Purpose: Identifying inhibitors of demethylase
for the treatment of prostate, breast, and skin cancer.
2.Assay Principle:

More Related Content

What's hot

CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystemsCRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystemsWenlan Hu
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Under the Radar: Alt...
MDC Connects Series 2021 | A Guide to Complex Medicines: Under the Radar: Alt...MDC Connects Series 2021 | A Guide to Complex Medicines: Under the Radar: Alt...
MDC Connects Series 2021 | A Guide to Complex Medicines: Under the Radar: Alt...Medicines Discovery Catapult
 
MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...
MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...
MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...Medicines Discovery Catapult
 
Alternative animal model for compound characterization
Alternative animal model for compound characterizationAlternative animal model for compound characterization
Alternative animal model for compound characterizationWenlan Hu
 
Good Model Organism for Anti Aging Testing
Good Model Organism for Anti Aging TestingGood Model Organism for Anti Aging Testing
Good Model Organism for Anti Aging TestingWenlan Hu
 
Molecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniquesMolecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniquesTheabhi.in
 
Kemxtree Presentation
Kemxtree PresentationKemxtree Presentation
Kemxtree Presentationguest44c9cb9c
 
Anticancer bioscience
Anticancer bioscienceAnticancer bioscience
Anticancer bioscienceJingZhang345
 
Session 6 part 2
Session 6 part 2Session 6 part 2
Session 6 part 2plmiami
 
TetraQ Services Presentation
TetraQ Services PresentationTetraQ Services Presentation
TetraQ Services Presentationsimonsend
 
Effects of Peptides and Amino Acids Derived from Oyster on Blood Lipids
Effects of Peptides and Amino Acids Derived from Oyster on Blood LipidsEffects of Peptides and Amino Acids Derived from Oyster on Blood Lipids
Effects of Peptides and Amino Acids Derived from Oyster on Blood LipidsSai Babitha
 
Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...MilliporeSigma
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Developing the assay...
MDC Connects Series 2021 | A Guide to Complex Medicines: Developing the assay...MDC Connects Series 2021 | A Guide to Complex Medicines: Developing the assay...
MDC Connects Series 2021 | A Guide to Complex Medicines: Developing the assay...Medicines Discovery Catapult
 
GtoPdb: A resource for cell-based perturbogens
GtoPdb:  A resource for cell-based perturbogensGtoPdb:  A resource for cell-based perturbogens
GtoPdb: A resource for cell-based perturbogensChris Southan
 
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...MilliporeSigma
 
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...Andrew McEachran
 
Low cost nutraceutical hypothesis testing
Low cost nutraceutical hypothesis testingLow cost nutraceutical hypothesis testing
Low cost nutraceutical hypothesis testingWenlan Hu
 

What's hot (20)

CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystemsCRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
 
Drug discovery hit to lead
Drug discovery hit to leadDrug discovery hit to lead
Drug discovery hit to lead
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Under the Radar: Alt...
MDC Connects Series 2021 | A Guide to Complex Medicines: Under the Radar: Alt...MDC Connects Series 2021 | A Guide to Complex Medicines: Under the Radar: Alt...
MDC Connects Series 2021 | A Guide to Complex Medicines: Under the Radar: Alt...
 
MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...
MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...
MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...
 
Alternative animal model for compound characterization
Alternative animal model for compound characterizationAlternative animal model for compound characterization
Alternative animal model for compound characterization
 
Good Model Organism for Anti Aging Testing
Good Model Organism for Anti Aging TestingGood Model Organism for Anti Aging Testing
Good Model Organism for Anti Aging Testing
 
Molecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniquesMolecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniques
 
Kemxtree Presentation
Kemxtree PresentationKemxtree Presentation
Kemxtree Presentation
 
Anticancer bioscience
Anticancer bioscienceAnticancer bioscience
Anticancer bioscience
 
Session 6 part 2
Session 6 part 2Session 6 part 2
Session 6 part 2
 
TetraQ Services Presentation
TetraQ Services PresentationTetraQ Services Presentation
TetraQ Services Presentation
 
Effects of Peptides and Amino Acids Derived from Oyster on Blood Lipids
Effects of Peptides and Amino Acids Derived from Oyster on Blood LipidsEffects of Peptides and Amino Acids Derived from Oyster on Blood Lipids
Effects of Peptides and Amino Acids Derived from Oyster on Blood Lipids
 
fda
fdafda
fda
 
Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Developing the assay...
MDC Connects Series 2021 | A Guide to Complex Medicines: Developing the assay...MDC Connects Series 2021 | A Guide to Complex Medicines: Developing the assay...
MDC Connects Series 2021 | A Guide to Complex Medicines: Developing the assay...
 
GtoPdb: A resource for cell-based perturbogens
GtoPdb:  A resource for cell-based perturbogensGtoPdb:  A resource for cell-based perturbogens
GtoPdb: A resource for cell-based perturbogens
 
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
 
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
 
Research Proposal
Research ProposalResearch Proposal
Research Proposal
 
Low cost nutraceutical hypothesis testing
Low cost nutraceutical hypothesis testingLow cost nutraceutical hypothesis testing
Low cost nutraceutical hypothesis testing
 

Similar to X-chem Poster Zooey

Process development
Process developmentProcess development
Process development9160676107
 
Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)Jannat985397
 
Best compound characterization protocol
Best compound characterization protocolBest compound characterization protocol
Best compound characterization protocolWenlan Hu
 
Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915Sitec Labs
 
Mode of action analysis
Mode of action analysisMode of action analysis
Mode of action analysisWenlan Hu
 
MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016Jonathan Duckworth
 
PreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdfPreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdfsayedjannatfatema72
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.Audumbar Mali
 
Finding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging DrugsFinding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging DrugsWenlan Hu
 
Bristol-Myer Squibb Report
Bristol-Myer Squibb ReportBristol-Myer Squibb Report
Bristol-Myer Squibb ReportRay Parker
 
Discovering New Innovations in Oncology
Discovering New Innovations in OncologyDiscovering New Innovations in Oncology
Discovering New Innovations in OncologyInsideScientific
 
SMi Group's Drug Discovery 2018
SMi Group's Drug Discovery 2018SMi Group's Drug Discovery 2018
SMi Group's Drug Discovery 2018Dale Butler
 
High Quality Integrated Drug R&D Services
High Quality Integrated Drug R&D ServicesHigh Quality Integrated Drug R&D Services
High Quality Integrated Drug R&D Servicesmedicilonz
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES anubhavdubey18
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptxashharnomani
 

Similar to X-chem Poster Zooey (20)

Process development
Process developmentProcess development
Process development
 
Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)
 
Best compound characterization protocol
Best compound characterization protocolBest compound characterization protocol
Best compound characterization protocol
 
Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915
 
Mode of action analysis
Mode of action analysisMode of action analysis
Mode of action analysis
 
MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016
 
CV_Mohammed Akhlaq
CV_Mohammed AkhlaqCV_Mohammed Akhlaq
CV_Mohammed Akhlaq
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
 
Principles of drug discovery
Principles of drug discoveryPrinciples of drug discovery
Principles of drug discovery
 
PreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdfPreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdf
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.
 
Finding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging DrugsFinding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging Drugs
 
Bristol-Myer Squibb Report
Bristol-Myer Squibb ReportBristol-Myer Squibb Report
Bristol-Myer Squibb Report
 
Discovering New Innovations in Oncology
Discovering New Innovations in OncologyDiscovering New Innovations in Oncology
Discovering New Innovations in Oncology
 
SMi Group's Drug Discovery 2018
SMi Group's Drug Discovery 2018SMi Group's Drug Discovery 2018
SMi Group's Drug Discovery 2018
 
Process research overview
Process research  overviewProcess research  overview
Process research overview
 
High Quality Integrated Drug R&D Services
High Quality Integrated Drug R&D ServicesHigh Quality Integrated Drug R&D Services
High Quality Integrated Drug R&D Services
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
 
anali chem.docx
anali chem.docxanali chem.docx
anali chem.docx
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptx
 

X-chem Poster Zooey

  • 1. Acknowledgements Overview of X-Chem Internship Description Skills and Knowledge Biochemistry Research Associate Intern in X-Chem Pharmaceuticals Jingyi (Zooey) Wang X-Chem, Inc 100 Beaver Street, Suite 101, Waltham, MA 02453-8425, USA Science of X-Chem 1.Overview X-Chem is a privately held biotechnology company established in 2009, whose chemical strategy can be applied broadly to most targets in any therapeutic area. A strong team of leading experts has been built with proven track records in innovative drug discovery and biotechnology partnering. 2.Development History X-Chem was founded in 2009 by industry veterans Richard Wagner, Brant Binder and Gordon Binder. A strategic partnership of X-Chem and Pharmaceutical Product Development , LLC(PPD) was formed in 2010. In 2014, PPD exercised its option to acquire all remaining interests in X- Chem, while the company’s management, scientific staff and biotechnology business model was retained. 3.Partners The company has established collaborations with eight of the leading pharmaceutical companies, top tier biotechnology companies, academic centers as well as non-profit institutions. Novel lead compounds has been generated against dozens of high-value therapeutic targets. When and How I got this position? I applied the Internship position through Massachusetts Life Science Internship Challenge (MSLC) in January of 2016. In the middle of March, with Dr. Neil Simister’s recommendation, I got the position at X-Chem and started working full-time at May 12. I have been working under the Biochemistry and Cell Biology group and under the supervising by Julie Liu, Senior Research Scientist. 1. Skills and knowledge I had that were useful in the internship. • The Background Knowledge learned from Molecular Biotechnology, Advanced cell Biology courses. • Experiment skills gained from Project Lab and Biochemistry Lab courses. 2. Gained Skills and Knowledge from Internship • Knowledge a. Drug discovery and business b. Troubleshoot experiment c. Lab Technics • Multiple Biochemistry assays a. ELISA Assay b. AlphaLISA Assay c. Malachite Green Assay d. Solubility assay • Instruments a. Mosquito: Multichannel dispenser which can dispense lower to 20nl. b. Multidrop Dispensers: Dispense reagents into plate and fill plate in seconds. c. Multichannel Pipettes d. Microplate Washers: Microplate strip washers provide secure washing performance for routine and research ELISA applications. • Data Analysis My Contribution to X-Chem What I did during the internship? • Prepare stock for compounds • Perform biochemical assays • Analyze data • Present results in the group meeting • Keep track of the compound inventory • Keep a record • X-Fit I would like to thank Dr. Neil Simister, X-Chem and MSLC internship challenge for providing me the opportunity to work and learn throughout the internship. I would like to thank my supervisor Julie Liu and the biochemistry and cell biology group member for all the help, patience and mentorship during the internship. Phase1: Library design and synthesis - Both chemistry and encoding steps occurring during the split. Phase2: Affinity Selection of library - Using affinity-tagged protein target yields a selected population of library members. Phase3: Amplification, Clustering and Sequencing (Illumina) - Giving a very deep sampling of the demographics of the enriched population. Phase4: Translation of Sequence - Providing chemical and statistical information and the sequence is evaluated to discover putative chemotypes. Phase5: Off-DNA compounds synthesis - Representative compounds exploring putative chemotypes with the desired enrichment profiles are synthesized off-DNA. Phase6: Biochemical assay - Target modulation is assessed by biochemical assay. Figure A Figure B Figure A: Inhibition curve for one compound (XCMPD004206). The y-axis shows the percentage of inhibition of target activity and the x-axis shows the concentration of compound in log scale. The 50% inhibition concentration for this compound is 0.002789uM. Figure B: Solubility curve for one compound (XCMPD004928). The y-axis shows the counts from Photodetector and the x-axis shows the concentration of compound in log scale. The solubility for this compound is 77.95uM Program 3: Malachite Green Assay 1.Program Purpose: Identifying inhibitors of the target for the treatment of autoimmune diseases, cancer. 2.Assay Principle: Program 4: Solubility Assay 1.Program Purpose: Setting up the solubility database for compounds of X-Chem. The solubility data can help the group to evaluate the compounds. 2.Assay Principle: Detects particles in liquid samples by measuring forward scattered light. Program 1: ELISA Assay 1.Program Purpose: Identifying inhibitors of the target which is related to potent anaphylatoxin, cell Lysis, proinflammatory, prothrombotic, chemotaxis. 2.Assay principle: Program 2: AlphaLISA Assay 1.Program Purpose: Identifying inhibitors of demethylase for the treatment of prostate, breast, and skin cancer. 2.Assay Principle: